Aurora Biotechnologies has entered into a worldwide distribution agreement with Beckman Coulter, which becomes a key distribution partner for Aurora's line of ChemLib microplates
"Beckman Coulter has recognised the importance that assay miniaturization brings to the discovery sciences.
"We are very excited to be able to offer Aurora's ChemLib microplates to our customers.
"The ChemLib microplates, packaged with our liquid-handling and detection instrumentation technologies, allow us to offer our customers a total miniaturization solution," said Chris Neary, vice president of automation at Beckman Coulter.
"We are pleased to have Beckman Coulter as a channel partner, leveraging their strong presence in the drug discovery and genomics marketplace.
"Beckman Coulter's reputation for quality and reliability is a perfect match for our products to deliver total miniaturization science solutions," added Larry Lugo, CEO, Aurora Biotechnologies.
Formed by the principals of Aurora Discovery, Aurora Biotechnologies provides products and services used in early-stage pharmaceutical research, particularly drug discovery and chemical genomics.
Aurora Biotechnologies, located in Carlsbad, California, is focused on the development and commercialization of microplate products and services, including its proven ChemLib high-density microplate products.
Aurora will focus its future on the ChemLib microplate products and other new and unique microplate designs suited for drug discovery, genomics, proteomics and cell biology markets.
